Collegium Pharmaceutical, Inc. Aktie News
30,30 €
0,95 %
L&S,
24. Oktober, 22:53 Uhr
Index
Industrie
tracken
Collegium Pharmaceutical, Inc. Aktie News
Neutral
GlobeNewsWire
●
4 Tage alt
STOUGHTON, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025.
Neutral
GlobeNewsWire
●
5 Tage alt
STOUGHTON, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have poster presentations highlighting real-world data from its differentiated neuropsychiatry product, Jornay PM, (methylphenidate HCl), a central nervous system (CNS) stimulant for the treatment of attention deficit hyperactivity disorder (ADHD) in people 6 years of age an...
Neutral
GlobeNewsWire
●
14 Tage alt
STOUGHTON, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management team will ring the Nasdaq opening bell on October 14, 2025 at 9:30 a.m.
Neutral
Seeking Alpha
●
etwa 2 Monate alt
Collegium Pharmaceutical, Inc. (NASDAQ:COLL ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Company Participants Vikram Karnani - CEO, President, Executive VP & Director Scott Dreyer - Executive VP & Chief Commercial Officer Colleen Tupper - Executive VP & CFO Conference Call Participants Robert Klingenberger Presentation Robert Klingenberger Good afterno...
Neutral
GlobeNewsWire
●
etwa 2 Monate alt
STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025Boston, MA Morgan Stanley 23rd Annual Global Healthcare Conference Fireside Chat Date and Time: Monday, September 8, 2025 at 2:35 p.m.
Neutral
GlobeNewsWire
●
2 Monate alt
STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain portfolio at PAINWeek 2025, taking place in Las Vegas, NV, September 2-5, 2025.
Neutral
Seeking Alpha
●
3 Monate alt
Collegium Pharmaceutical, Inc. (NASDAQ:COLL ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Colleen Tupper - Executive VP & CFO Ian Karp - Corporate Participant Scott Dreyer - Executive VP & Chief Commercial Officer Vikram Karnani - CEO, President, Executive VP & Director Conference Call Participants David A. Amsellem - Piper Sandler & Co., Research Division Jo...
Positiv
The Motley Fool
●
3 Monate alt
Collegium (COLL) Q2 Revenue Jumps 29%
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
